A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

NCT06680128 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Japanese Encephalitis Virus Disease

Interventions

BIOLOGICAL: GBP560-A
BIOLOGICAL: GBP560-B
BIOLOGICAL: IXIARO
BIOLOGICAL: IMOJEV
BIOLOGICAL: Normal Saline (Placebo)

Sponsor

SK Bioscience Co., Ltd.